Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.000
-0.050 (-2.44%)
At close: Sep 11, 2026, 4:00 PM EDT
2.030
+0.030 (1.50%)
After-hours: Sep 11, 2026, 7:58 PM EDT
Compass Therapeutics Employees
Compass Therapeutics had 39 employees as of December 31, 2025. The number of employees increased by 4 or 11.43% compared to the previous year.
Employees
39
Change (1Y)
4
Growth (1Y)
11.43%
Revenue / Employee
n/a
Profits / Employee
-$1,883,231
Market Cap
360.18M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 39 | 4 | 11.43% |
| Dec 31, 2024 | 35 | 3 | 9.38% |
| Dec 31, 2023 | 32 | 6 | 23.08% |
| Dec 31, 2022 | 26 | 2 | 8.33% |
| Dec 31, 2021 | 24 | -7 | -22.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EyePoint | 214 |
| Rocket Pharmaceuticals | 202 |
| Ocugen | 116 |
| Orchestra BioMed Holdings | 86 |
| Century Therapeutics | 78 |
| Lexeo Therapeutics | 63 |
| Sionna Therapeutics | 59 |
| X4 Pharmaceuticals | 45 |
CMPX News
- 5 weeks ago - Compass Therapeutics price target raised to $7 from $4 at Leerink - TheFly
- 5 weeks ago - Compass Therapeutics Reports 2026 Second Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 5 weeks ago - Compass Therapeutics Earnings release: Q2 2026 - Filings
- 5 weeks ago - Compass Therapeutics Quarterly report: Q2 2026 - Filings
- 1 month ago - Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026 - GlobeNewsWire
- 3 months ago - Compass Therapeutics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 3 months ago - Compass Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 3 months ago - Compass Therapeutics to Participate in Upcoming June Investor Events - GlobeNewsWire